Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Exploring efficiencies from eTMF with Cancer Research UK
  2. GSK’s Zejula meets primary goal in Phase III ovarian cancer trial
  3. Trials data suggests Cosentyx from Novartis will change psoriasis market
  4. Eligibility criteria for clinical trials report challenges in representing LN patients
  5. Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities

Latest Content

3DforScience Showed its Visual Solutions at ESMO Congress Barcelona

The European Society for Medical Oncology (ESMO) Congress took place Barcelona from 27 September to 1 October 2019. This was an annual gathering of the leading European professional organisation for medical oncology, with more than 17,000 oncology professionals from over 130 countries.

November’s top news stories

Eli Lilly and Boehringer Ingelheim started a Phase III clinical trial, EMPULSE, to evaluate whether Jardiance (empagliflozin) improves acute heart failure, and The Janssen Pharmaceutical Companies of Johnson & Johnson is reimagining digital clinical trial design with the launch of a new study. Clinicaltrialsarena.com wraps up key headlines from November 2019.

Latest News

Close
Close
Close

Go Top